BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28641561)

  • 1. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg.
    Chen Q; Li W; Wang P; Shao H; Ding Y; Wang W; Cen D; Cai Y; Xue X; Zhang L; Zhu G
    Protein Pept Lett; 2017; 24(10):947-954. PubMed ID: 28641561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major Immunodominant Region of Hepatitis B Virus Core Antigen as a Delivery Vector to Improve the Immunogenicity of the Fusion Antigen ROP2-SAG1 Multiepitope from Toxoplasma gondii in Mice.
    Wang W; Feng F; Lv J; Xie Z; Chen J; Zhang L; Li W
    Viral Immunol; 2017 Sep; 30(7):508-515. PubMed ID: 28436740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immunodominant epitopes derived from MAGE-A3 and its significance in serological diagnosis of gastric cancer.
    Shen X; Jin J; Ding Y; Wang P; Wang A; Xiao D; Xue X; Zhu S; Zhang L; Zhu G
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1529-38. PubMed ID: 23842851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a multiepitope plasmid DNA encoding T and B lymphocyte epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a vaccine in mice.
    Li W; Chen Q; Lin Q; Lv Y; Feng J; Liu J; Xu W; Chen S; Zhu X; Zhang L
    Protein Pept Lett; 2013 Oct; 20(10):1136-43. PubMed ID: 23688153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of hepatitis C virus vaccine using hepatitis B core antigen as immuno-carrier.
    Chen JY; Li F
    World J Gastroenterol; 2006 Dec; 12(48):7774-8. PubMed ID: 17203519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.
    Tsuji T; Altorki NK; Ritter G; Old LJ; Gnjatic S
    J Immunol; 2009 Oct; 183(7):4800-8. PubMed ID: 19734225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
    Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
    Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles.
    Kobayashi H; Song Y; Hoon DS; Appella E; Celis E
    Cancer Res; 2001 Jun; 61(12):4773-8. PubMed ID: 11406551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
    Chen X; Lai J; Pan Q; Tang Z; Yu Y; Zang G
    Vaccine; 2010 May; 28(23):3913-9. PubMed ID: 20394723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model.
    Chu X; Li Y; Long Q; Xia Y; Yao Y; Sun W; Huang W; Yang X; Liu C; Ma Y
    Int J Nanomedicine; 2016; 11():2417-29. PubMed ID: 27313455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myeloma.
    Szmania S; Gnjatic S; Tricot G; Stone K; Zhan F; Moreno A; Thuro B; Melenhorst J; Barrett J; Shaughnessy J; Old LJ; Barlogie B; Brichard VG; van Rhee F
    J Immunother; 2007; 30(8):847-54. PubMed ID: 18049337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.
    Lin L; Wei J; Chen Y; Huang A; Li KK; Zhang W
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):281-9. PubMed ID: 24322180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice].
    Huang Z; Lu S; Liu N
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):456-9. PubMed ID: 11715443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGE-A3 with cell-penetrating domain as an efficient therapeutic cancer vaccine.
    Batchu RB; Gruzdyn O; Potti RB; Weaver DW; Gruber SA
    JAMA Surg; 2014 May; 149(5):451-7. PubMed ID: 24671426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region.
    Street M; Herd K; Londono P; Doan T; Dougan G; Kast WM; Tindle RW
    Arch Virol; 1999; 144(7):1323-43. PubMed ID: 10481740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.